Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...
Arcus Biosciences reports 26.7-month median survival and 59% response rate in Phase 2 cancer study with domvanalimab ...
One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical ...
Omeros (OMER) announced the publication of a peer-reviewed manuscript in an American Society of Hematology journal, Blood Advances. The manuscript ...
Ever stared down a case of spinal or pelvic diffuse large B-cell lymphoma (SP-DLBCL) and thought, “I could surely use a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback